US Patent 8338485 Compositions for the treatment of CNS-related conditions

Patent 8338485 was granted and assigned to Adamas Pharmaceuticals, Inc. on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83384850

Patent Inventor Names

Gregory T. Went0

Timothy J. Fultz0

Laurence R. Meyerson0

Date of Patent

December 25, 2012

Patent Application Number

135365880

Date Filed

June 28, 2012

Patent Citations Received

‌

US Patent 11903908 Methods of administering amantadine

Patent Primary Examiner

‌

Sreeni Padmanabhan

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8338485 Compositions for the treatment of CNS-related conditions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.